Oxford, United Kingdom

Peter A Feldman


Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Blood Clotting: The Contributions of Peter A. Feldman

Introduction

Peter A. Feldman is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical science, particularly in the area of blood clotting factors. His innovative approach has the potential to enhance the treatment of patients requiring blood clotting therapies.

Latest Patents

Feldman's most recent patent is titled "Process for purifying blood clotting factors." This patent describes a method for at least partially separating vitamin K-dependent blood clotting factors from a mixture containing at least one such factor, such as a prothrombin complex concentrate. The process involves the adsorption of the mixture onto a chelate of a polyvalent metal immobilized on an inert support, specifically using Cu²⁺-primed Chelating Sepharose, followed by elution to yield one or more fractions enriched in respect of one of the factors. This innovative method has the potential to improve the efficiency and effectiveness of blood clotting treatments.

Career Highlights

Peter A. Feldman is associated with the National Blood Authority, where he applies his expertise in blood clotting factors. His work at this institution underscores his commitment to advancing medical science and improving patient outcomes. With a focus on innovation, Feldman continues to contribute to the field through his research and patent developments.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Peter A. Feldman's contributions to the field of blood clotting factors through his innovative patent demonstrate his dedication to improving medical treatments. His work has the potential to significantly impact patient care and enhance the effectiveness of blood clotting therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…